Royce W. Chen, BA
Jay S. Duker, MD
(Boston, Massachusetts, U.S.A.) |
Interpretation of OCT: Pearls in Macular Degeneration
Volume 34, Number # 6, 2006 Series
Royce W. Chen, BA
Jay S. Duker, MD
(Boston, Massachusetts, U.S.A.) |
1. Klein R, Klein BE, Jensen SC, et al. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 1997;104:7-21.
2. Klein R, Klein BE, Tomany SC, et al. Ten-year incidence and progression of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology 2002;109:1767-79.
3. Leibowitz HM, Krueger DE, Maunder LR, et al. The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol 1980;24:335-610.
4. Friedman E. The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration. Am J Ophthalmol 2000;130:658-63.
5. Pieroni CG, Witkin AJ, Ko TH, et al. Ultrahigh resolution optical coherence tomography in non-exudative age related macular degeneration. Br J Ophthalmol 2006;90:191-97.
6. Macular diseases. In: Berkow JW, Flower RW, Orth DH, Kelley JS, eds. Fluorescein and Indocyanine Green Angiography-Technique and Interpretation. San Francisco, CA: American Academy of Ophthalmology;1997:91-103.
7. Ozdemir H. Karacorlu SA. Karacorlu M. Early optical coherence tomography changes after photodynamic therapy in patients with age-related macular degeneration. Am J Ophthalmol. 2006;141(3):574-6.
8. Rogers AH, Martidis A, Greenberg PB, Puliafito CA. Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization. Am J Ophthalmol 2002;134:566-76.
9. Costa RA, Farah ME, Cardillo JA, et al. Immediate indocyanine green angiography and optical coherence tomography evaluation after photodynamic therapy for subfoveal choroidal neovascularization. Retina 2003;23:159-65.
10. Rosenfelt PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. [see comment]. Ophthalmic Surgery, Lasers & Imaging. 2005;36(4):331-5.
11. Schuman S, Rogers AH, Duker JS, et al. Six-week outcomes after pegaptanib. Ophthalmology 2006;113(3):501
12. Bashshur ZF, Bazarbachi A, Schakal A, et al. Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration.[see comment]. Am J Ophthalmol. 2006;142(1):141-3.
|
